Tailoring of membrane proteins by alternative splicing of Pre-mRNA

Biochemistry

Volumn 51, Issue 28, 2012, Pages 5541-5556

  Mittendorf, Kathleen F ^a   Deatherage, Catherine L ^a   Ohi, Melanie D ^a   Sanders, Charles R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE SPLICING; ALZHEIMERS DISEASE; INTEGRAL MEMBRANE PROTEINS; MEMBRANE PROTEINS; PRE-MRNA; PROTEIN STRUCTURES; THERAPEUTIC TARGETS;

BIOLOGICAL MEMBRANES; RNA;

PROTEINS;

G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA PRECURSOR; PROTEOLIPID PROTEIN; RYANODINE RECEPTOR; SNARE PROTEIN; TRANSCRIPTOME;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; EXON; EXTRACELLULAR MATRIX; HUMAN; INTRON; MYOTONIC DYSTROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; RNA PROCESSING; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; ANIMALS; HUMANS; INTRONS; MEMBRANE PROTEINS; ORGAN SPECIFICITY; PROTEIN FOLDING; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; RNA PRECURSORS; RNA, MESSENGER;

EUKARYOTA;

EID: 84863957982     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi3007065     Document Type: Article

References (154)

1. Beadle, G. W. and Tatum, E. L. (1941) Genetic Control of Biochemical Reactions in Neurospora Proc. Natl. Acad. Sci. U.S.A. 27, 499-506
2. Chow, L. T., Roberts, J. M., Lewis, J. B., and Broker, T. R. (1977) A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids Cell 11, 819-836
3. Berget, S. M., Moore, C., and Sharp, P. A. (1977) Spliced segments at the 5′ terminus of adenovirus 2 late mRNA Proc. Natl. Acad. Sci. U.S.A. 74, 3171-3175
4. Gilbert, W. (1978) Why genes in pieces? Nature 271, 501
5. Medford, R. M., Nguyen, H. T., Destree, A. T., Summers, E., and Nadal-Ginard, B. (1984) A novel mechanism of alternative RNA splicing for the developmentally regulated generation of troponin T isoforms from a single gene Cell 38, 409-421
6. Matlin, A. J. and Moore, M. J. (2007) Spliceosome assembly and composition Adv. Exp. Med. Biol. 623, 14-35
7. Grainger, R. J. and Beggs, J. D. (2007) Spliceosomal Machinery. In eLS, John Wiley & Sons, Ltd., New York (DOI: 10.1002/9780470015902.a0000889.pub2) .
8. Will, C. L. and Luhrmann, R. (2011) Spliceosome structure and function Cold Spring Harbor Perspect. Biol. 3 10.1101/cshperspect.a003707
9. Wahl, M. C., Will, C. L., and Luhrmann, R. (2009) The spliceosome: Design principles of a dynamic RNP machine Cell 136, 701-718
10. Mount, S. M. (2001) Messenger RNA Splicing Signals. In eLS, John Wiley & Sons, Ltd., New York (DOI: 10.1038/npg.els.0000888).
11. Lu, Y.-S. and Tarn, W.-Y. (2010) Splicing of Pre-mRNA. In eLS, John Wiley & Sons, Ltd., New York (DOI: 10.1002/9780470015902.a0005037.pub2).
12. Chang, Y. F., Imam, J. S., and Wilkinson, M. F. (2007) The nonsense-mediated decay RNA surveillance pathway Annu. Rev. Biochem. 76, 51-74
13. Baker, K. E. and Parker, R. (2004) Nonsense-mediated mRNA decay: Terminating erroneous gene expression Curr. Opin. Cell Biol. 16, 293-299
14. Brogna, S. and Wen, J. (2009) Nonsense-mediated mRNA decay (NMD) mechanisms Nat. Struct. Mol. Biol. 16, 107-113
15. Maquat, L. E. (2004) Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics Nat. Rev. Mol. Cell Biol. 5, 89-99
16. Mendell, J. T. and Dietz, H. C. (2006) Nonsense-mediated mRNA Decay. In eLS, John Wiley & Sons, Ltd., New York (DOI: 10.1038/npg.els.0005501).
17. Keren, H., Lev-Maor, G., and Ast, G. (2010) Alternative splicing and evolution: Diversification, exon definition and function Nat. Rev. Genet. 11, 345-355
18. Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., and Burge, C. B. (2008) Alternative isoform regulation in human tissue transcriptomes Nature 456, 470-476
19. Koralewski, T. E. and Krutovsky, K. V. (2011) Evolution of exon-intron structure and alternative splicing PLoS One 6, e18055
20. Sakharkar, M. K., Chow, V. T., and Kangueane, P. (2004) Distributions of exons and introns in the human genome In Silico Biol. 4, 387-393
21. Nilsen, T. W. and Graveley, B. R. (2010) Expansion of the eukaryotic proteome by alternative splicing Nature 463, 457-463
22. Breitbart, R. E., Andreadis, A., and Nadal-Ginard, B. (1987) Alternative splicing: A ubiquitous mechanism for the generation of multiple protein isoforms from single genes Annu. Rev. Biochem. 56, 467-495
23. Sammeth, M., Foissac, S., and Guigo, R. (2008) A general definition and nomenclature for alternative splicing events PLoS Comput. Biol. 4, e1000147
24. Pillmann, H., Hatje, K., Odronitz, F., Hammesfahr, B., and Kollmar, M. (2011) Predicting mutually exclusive spliced exons based on exon length, splice site and reading frame conservation, and exon sequence homology BMC Bioinf. 12, 270
25. Moore, M. J. and Sharp, P. A. (1993) Evidence for two active sites in the spliceosome provided by stereochemistry of pre-mRNA splicing Nature 365, 364-368
26. Gornemann, J., Kotovic, K. M., Hujer, K., and Neugebauer, K. M. (2005) Cotranscriptional spliceosome assembly occurs in a stepwise fashion and requires the cap binding complex Mol. Cell 19, 53-63
27. Tardiff, D. F. and Rosbash, M. (2006) Arrested yeast splicing complexes indicate stepwise snRNP recruitment during in vivo spliceosome assembly RNA 12, 968-979
28. Hoskins, A. A., Friedman, L. J., Gallagher, S. S., Crawford, D. J., Anderson, E. G., Wombacher, R., Ramirez, N., Cornish, V. W., Gelles, J., and Moore, M. J. (2011) Ordered and dynamic assembly of single spliceosomes Science 331, 1289-1295
29. Padgett, R. A. and Burge, C. B. (2005) Splice Sites. In eLS, John Wiley & Sons, Ltd., New York (DOI: 10.1038/npg.els.0005044).
30. Smith, C. W. and Valcarcel, J. (2000) Alternative pre-mRNA splicing: The logic of combinatorial control Trends Biochem. Sci. 25, 381-388
31. Wang, Z. and Burge, C. B. (2008) Splicing regulation: From a parts list of regulatory elements to an integrated splicing code RNA 14, 802-813
32. Buratti, E. and Baralle, F. E. (2004) Influence of RNA secondary structure on the pre-mRNA splicing process Mol. Cell. Biol. 24, 10505-10514
33. Shepard, P. J. and Hertel, K. J. (2008) Conserved RNA secondary structures promote alternative splicing RNA 14, 1463-1469
34. Yang, Y., Zhan, L., Zhang, W., Sun, F., Wang, W., Tian, N., Bi, J., Wang, H., Shi, D., Jiang, Y., Zhang, Y., and Jin, Y. (2011) RNA secondary structure in mutually exclusive splicing Nat. Struct. Mol. Biol. 18, 159-168
35. Luco, R. F., Pan, Q., Tominaga, K., Blencowe, B. J., Pereira-Smith, O. M., and Misteli, T. (2010) Regulation of alternative splicing by histone modifications Science 327, 996-1000
36. Holste, D. and Ohler, U. (2008) Strategies for identifying RNA splicing regulatory motifs and predicting alternative splicing events PLoS Comput. Biol. 4, e21
37. Thanaraj, T. A. and Robinson, A. J. (2000) Prediction of exact boundaries of exons Briefings Bioinf. 1, 343-356
38. Jones, S. J. (2006) Prediction of genomic functional elements Annu. Rev. Genomics Hum. Genet. 7, 315-338
39. Thanaraj, T. A. and Stamm, S. (2003) Prediction and statistical analysis of alternatively spliced exons Prog. Mol. Subcell. Biol. 31, 1-31
40. Barash, Y., Calarco, J. A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B. J., and Frey, B. J. (2010) Deciphering the splicing code Nature 465, 53-59
41. Tejedor, J. R. and Valcarcel, J. (2010) Gene regulation: Breaking the second genetic code Nature 465, 45-46
42. Cline, M. S., Shigeta, R., Wheeler, R. L., Siani-Rose, M. A., Kulp, D., and Loraine, A. E. (2004) The effects of alternative splicing on transmembrane proteins in the mouse genome Pac. Symp. Biocomput. 2004, 17-28
43. Garcia-Blanco, M. A., Baraniak, A. P., and Lasda, E. L. (2004) Alternative splicing in disease and therapy Nat. Biotechnol. 22, 535-546
44. Tazi, J., Bakkour, N., and Stamm, S. (2009) Alternative splicing and disease Biochim. Biophys. Acta 1792, 14-26
45. Faustino, N. A. and Cooper, T. A. (2003) Pre-mRNA splicing and human disease Genes Dev. 17, 419-437
46. Wang, G. S. and Cooper, T. A. (2007) Splicing in disease: Disruption of the splicing code and the decoding machinery Nat. Rev. Genet. 8, 749-761
47. Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., and Soreq, H. (2005) Function of alternative splicing Gene 344, 1-20
48. Avent, N. D. and Reid, M. E. (2000) The Rh blood group system: A review Blood 95, 375-387
49. Le Van Kim, C., Cherif-Zahar, B., Raynal, V., Mouro, I., Lopez, M., Cartron, J. P., and Colin, Y. (1992) Multiple Rh messenger RNA isoforms are produced by alternative splicing Blood 80, 1074-1078
50. Gonzalez, A., Borquez, M., Trigo, C. A., Brenet, M., Sarmiento, J. M., Figueroa, C. D., Navarro, J., and Gonzalez, C. B. (2011) The splice variant of the V2 vasopressin receptor adopts alternative topologies Biochemistry 50, 4981-4986
51. Oertel, J., Villmann, C., Kettenmann, H., Kirchhoff, F., and Becker, C. M. (2007) A novel glycine receptor β subunit splice variant predicts an unorthodox transmembrane topology. Assembly into heteromeric receptor complexes J. Biol. Chem. 282, 2798-2807
52. Davis, M. J., Hanson, K. A., Clark, F., Fink, J. L., Zhang, F., Kasukawa, T., Kai, C., Kawai, J., Carninci, P., Hayashizaki, Y., and Teasdale, R. D. (2006) Differential Use of Signal Peptides and Membrane Domains is a Common Occurence in the Protein Output of Transcriptional Units PLoS Genet. 2, 0554-0563
53. von Heijne, G. (2006) Membrane-protein topology Nat. Rev. Mol. Cell Biol. 7, 909-918
54. Joun, H., Lanske, B., Karperien, M., Qian, F., Defize, L., and Abou-Samra, A. (1997) Tissue-specific transcription start sites and alternative splicing of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor gene: A new PTH/PTHrP receptor splice variant that lacks the signal peptide Endocrinology 138, 1742-1749
55. Xing, Y., Xu, Q., and Lee, C. (2003) Widespread production of novel soluble protein isoforms by alternative splicing removal of transmembrane anchoring domains FEBS Lett. 555, 572-578
56. Fitzgerald, M. L., Wang, Z., Park, P. W., Murphy, G., and Bernfield, M. (2000) Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase J. Cell Biol. 148, 811-824
57. Kawano, R., Matsuo, N., Tanaka, H., Nasu, M., Yoshioka, H., and Shirabe, K. (2002) Identification and characterization of a soluble cadherin-7 isoform produced by alternative splicing J. Biol. Chem. 277, 47679-47685
58. Vazquez, E. and Valverde, M. A. (2006) A review of TRP channels splicing Semin. Cell Dev. Biol. 17, 607-617
59. Bidaux, G., Beck, B., Zholos, A., Gordienko, D., Lemonnier, L., Flourakis, M., Roudbaraki, M., Borowiec, A. S., Fernandez, J., Delcourt, P., Lepage, G., Shuba, Y., Skryma, R., and Prevarskaya, N. (2012) Regulation of activity of transient receptor potential melastatin 8 (TRPM8) channel by its short isoforms J. Biol. Chem. 287, 2948-2962
60. Oberwinkler, J., Lis, A., Giehl, K. M., Flockerzi, V., and Philipp, S. E. (2005) Alternative splicing switches the divalent cation selectivity of TRPM3 channels J. Biol. Chem. 280, 22540-22548
61. 2+ pump is controlled by alternative splicing J. Biol. Chem. 269, 41-43
62. Lauriat, T. L. and McInnes, L. A. (2007) EAAT2 regulation and splicing: Relevance to psychiatric and neurological disorders Mol. Psychiatry 12, 1065-1078
63. Filmore, D. (2004) Its a GPCR World Mod. Drug Discovery, 24-28
64. Markovic, D. and Challiss, R. A. (2009) Alternative splicing of G protein-coupled receptors: Physiology and pathophysiology Cell. Mol. Life Sci. 66, 3337-3352
65. Kilpatrick, G. J., Dautzenberg, F. M., Martin, G. R., and Eglen, R. M. (1999) 7TM receptors: The splicing on the cake Trends Pharmacol. Sci. 20, 294-301
66. Minneman, K. P. (2001) Splice variants of G protein-coupled receptors Mol. Interventions 1, 108-116
67. Ryberg, E., Vu, H. K., Larsson, N., Groblewski, T., Hjorth, S., Elebring, T., Sjogren, S., and Greasley, P. J. (2005) Identification and characterisation of a novel splice variant of the human CB1 receptor FEBS Lett. 579, 259-264
68. Haapasalo, J., Hilvo, M., Nordfors, K., Haapasalo, H., Parkkila, S., Hyrskyluoto, A., Rantala, I., Waheed, A., Sly, W. S., Pastorekova, S., Pastorek, J., and Parkkila, A. K. (2008) Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas Neuro-Oncology (Durham, NC, U.S.) 10, 131-138
69. Gudz, T. I., Schneider, T. E., Haas, T. A., and Macklin, W. B. (2002) Myelin proteolipid protein forms a complex with integrins and may participate in integrin receptor signaling in oligodendrocytes J. Neurosci. 22, 7398-7407
70. Nave, K. A., Lai, C., Bloom, F. E., and Milner, R. J. (1987) Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin Proc. Natl. Acad. Sci. U.S.A. 84, 5665-5669
71. Weimbs, T. and Stoffel, W. (1992) Proteolipid protein (PLP) of CNS myelin: Positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP Biochemistry 31, 12289-12296
72. Lin, J. W., Wyszynski, M., Madhavan, R., Sealock, R., Kim, J. U., and Sheng, M. (1998) Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1 J. Neurosci. 18, 2017-2027
73. Feliciello, A., Cardone, L., Garbi, C., Ginsberg, M. D., Varrone, S., Rubin, C. S., Avvedimento, E. V., and Gottesman, M. E. (1999) Yotiao protein, a ligand for the NMDA receptor, binds and targets cAMP-dependent protein kinase II(1) FEBS Lett. 464, 174-178
74. Ehlers, M. D., Mammen, A. L., Lau, L. F., and Huganir, R. L. (1996) Synaptic targeting of glutamate receptors Curr. Opin. Cell Biol. 8, 484-489
75. Ehlers, M. D., Zhang, S., Bernhadt, J. P., and Huganir, R. L. (1996) Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit Cell 84, 745-755
76. Ferrera, L., Caputo, A., Ubby, I., Bussani, E., Zegarra-Moran, O., Ravazzolo, R., Pagani, F., and Galietta, L. J. (2009) Regulation of TMEM16A chloride channel properties by alternative splicing J. Biol. Chem. 284, 33360-33368
77. Suter, U., Snipes, G. J., Schoener-Scott, R., Welcher, A. A., Pareek, S., Lupski, J. R., Murphy, R. A., Shooter, E. M., and Patel, P. I. (1994) Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters J. Biol. Chem. 269, 25795-25808
78. Isenmann, S., Khew-Goodall, Y., Gamble, J., Vadas, M., and Wattenberg, B. W. (1998) A splice-isoform of vesicle-associated membrane protein-1 (VAMP-1) contains a mitochondrial targeting signal Mol. Biol. Cell 9, 1649-1660
79. Gough, N. R. and Fambrough, D. M. (1997) Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue J. Cell Biol. 137, 1161-1169
80. Ehehalt, R., Michel, B., De Pietri Tonelli, D., Zacchetti, D., Simons, K., and Keller, P. (2002) Splice variants of the β-site APP-cleaving enzyme BACE1 in human brain and pancreas Biochem. Biophys. Res. Commun. 293, 30-37
81. Bird, T. D. (2011) in Myotonic Dystrophy Type 1. 1999 Sep 17 [Updated 2011 Feb 8] (Pagon, R. A., Bird, T. D., and Dolan, C. R., et al., Eds.) GeneReviews [Internet], University of Washington, Seattle (http://www.ncbi.nlm. nih.gov/books/NBK1165/).
82. Mahadevan, M., Tsilfidis, C., Sabourin, L., Shutler, G., Amemiya, C., Jansen, G., Neville, C., Narang, M., Barcelo, J., and OHoy, K. 1992, Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene Science 255, 1253-1255
83. Harley, H. G., Rundle, S. A., MacMillan, J. C., Myring, J., Brook, J. D., Crow, S., Reardon, W., Fenton, I., Shaw, D. J., and Harper, P. S. (1993) Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy Am. J. Hum. Genet. 52, 1164-1174
84. Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T., and Thornton, C. A. (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons Hum. Mol. Genet. 13, 3079-3088
85. n triplet repeat RNA-binding protein and its expression in myotonic dystrophy Nucleic Acids Res. 24, 4407-4414
86. Kuyumcu-Martinez, N. M., Wang, G. S., and Cooper, T. A. (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation Mol. Cell 28, 68-78
87. n expansions associated with myotonic dystrophy EMBO J. 19, 4439-4448
88. Moller, D. E., Yokota, A., Caro, J. F., and Flier, J. S. (1989) Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man Mol. Endocrinol. 3, 1263-1269
89. Seino, S. and Bell, G. I. (1989) Alternative splicing of human insulin receptor messenger RNA Biochem. Biophys. Res. Commun. 159, 312-316
90. Knudsen, L., De Meyts, P., and Kiselyov, V. V. (2011) Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms Biochem. J. 440, 397-403
91. Savkur, R. S., Philips, A. V., and Cooper, T. A. (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy Nat. Genet. 29, 40-47
92. Charlet, B. N., Savkur, R. S., Singh, G., Philips, A. V., Grice, E. A., and Cooper, T. A. (2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing Mol. Cell 10, 45-53
93. Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T., and Thornton, C. A. (2007) Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy J. Clin. Invest. 117, 3952-3957
94. 2+ in malignant hyperthermia and central core disease Biochem. Biophys. Res. Commun. 322, 1256-1266
95. 2+-ATPase in myotonic dystrophy type 1 Hum. Mol. Genet. 14, 2189-2200
96. Futatsugi, A., Kuwajima, G., and Mikoshiba, K. (1995) Tissue-specific and developmentally regulated alternative splicing in mouse skeletal muscle ryanodine receptor mRNA Biochem. J. 305 (Part 2) 373-378
97. V1.1 calcium channel Hum. Mol. Genet. 21, 1312-1324
98. Thies, W. and Bleiler, L. (2011) 2011 Alzheimers disease facts and figures Alzheimer's Dementia 7, 208-244
99. Blennow, K., de Leon, M. J., and Zetterberg, H. (2006) Alzheimers disease Lancet 368, 387-403
100. Karran, E., Mercken, M., and De Strooper, B. (2011) The amyloid cascade hypothesis for Alzheimers disease: An appraisal for the development of therapeutics Nat. Rev. Drug Discovery 10, 698-712
101. Walsh, D. M. and Selkoe, D. J. (2007) Aβ oligomers: A decade of discovery J. Neurochem. 101, 1172-1184
102. Prox, J., Rittger, A., and Saftig, P. (2012) Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and Presenilin Exp. Brain Res. 217, 331-341
103. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S. M., Wang, S., Walker, D., Zhao, J., McConlogue, L., and John, V. (1999) Purification and cloning of amyloid precursor protein β-secretase from human brain Nature 402, 537-540
104. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M. (1999) β-Secretase cleavage of Alzheimers amyloid precursor protein by the transmembrane aspartic protease BACE Science 286, 735-741
105. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashier, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., Carter, D. B., Tomasselli, A. G., Parodi, L. A., Heinrikson, R. L., and Gurney, M. E. (1999) Membrane-anchored aspartyl protease with Alzheimers disease β-secretase activity Nature 402, 533-537
106. Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., and Tang, J. (2000) Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein Proc. Natl. Acad. Sci. U.S.A. 97, 1456-1460
107. Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S., and Selkoe, D. J. (2003) Secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2 Proc. Natl. Acad. Sci. U.S.A. 100, 6382-6387
108. Yoshikai, S., Sasaki, H., Doh-ura, K., Furuya, H., and Sakaki, Y. (1990) Genomic organization of the human amyloid β-protein precursor gene Gene 87, 257-263
109. Ling, Y., Morgan, K., and Kalsheker, N. (2003) Amyloid precursor protein (APP) and the biology of proteolytic processing: Relevance to Alzheimers disease Int. J. Biochem. Cell Biol. 35, 1505-1535
110. Ho, L., Fukuchi, K., and Younkin, S. G. (1996) The alternatively spliced Kunitz protease inhibitor domain alters amyloid β protein precursor processing and amyloid β protein production in cultured cells J. Biol. Chem. 271, 30929-30934
111. Tanahashi, H. and Tabira, T. (2001) Three novel alternatively spliced isoforms of the human β-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid β-peptide production Neurosci. Lett. 307, 9-12
112. Bodendorf, U., Fischer, F., Bodian, D., Multhaup, G., and Paganetti, P. (2001) A splice variant of β-secretase deficient in the amyloidogenic processing of the amyloid precursor protein J. Biol. Chem. 276, 12019-12023
113. Tanahashi, H. and Tabira, T. (2007) A novel β-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation Neurosci. Lett. 428, 103-108
114. Mowrer, K. R. and Wolfe, M. S. (2008) Promotion of BACE1 mRNA alternative splicing reduces amyloid β-peptide production J. Biol. Chem. 283, 18694-18701
115. Fisette, J. F., Montagna, D. R., Mihailescu, M. R., and Wolfe, M. S. (2012) A G-Rich Element Forms a G-Quadruplex and Regulates Bace1 mRNA Alternative Splicing J. Neurochem. 121, 763-773
116. Ahn, K., Shelton, C. C., Tian, Y., Zhang, X., Gilchrist, M. L., Sisodia, S. S., and Li, Y. M. (2010) Activation and intrinsic secretase activity of presenilin 1 Proc. Natl. Acad. Sci. U.S.A. 107, 21435-21440
117. Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., and Selkoe, D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and secretase activity Nature 398, 513-517
118. Figueroa, D. J., Morris, J. A., Ma, L., Kandpal, G., Chen, E., Li, Y. M., and Austin, C. P. (2002) Presenilin-dependent secretase activity modulates neurite outgrowth Neurobiol. Dis. 9, 49-60
119. Tolia, A. and De Strooper, B. (2009) Structure and function of secretase Semin. Cell Dev. Biol. 20, 211-218
120. Zhang, H., Ma, Q., Zhang, Y. W., and Xu, H. (2012) Proteolytic processing of Alzheimers β-amyloid precursor protein J. Neurochem. 120 (Suppl. 1) 9-21
121. De Strooper, B., Iwatsubo, T., and Wolfe, M. S. (2012) Presenilins and Secretase: Structure, Function, and Role in Alzheimer Disease Cold Spring Harbor Perspect. Med. 2, a006304
122. Scheper, W., Zwart, R., and Baas, F. (2004) Alternative splicing in the N-terminus of Alzheimers presenilin 1 Neurogenetics 5, 223-227
123. Isoe-Wada, K., Urakami, K., Wakutani, Y., Adachi, Y., Arai, H., Sasaki, H., and Nakashima, K. (1999) Alteration in brain presenilin-1 mRNA expression in sporadic Alzheimers disease Eur. J. Neurol. 6, 163-167
124. Barton, A. J., Crook, B. W., Karran, E. H., Brown, F., Dewar, D., Mann, D. M., Pearson, R. C., Graham, D. I., Hardy, J., Hutton, M., Duff, K., Goate, A. M., Clark, R. F., and Roberts, G. W. (1996) Alteration in brain presenilin 1 mRNA expression in early onset familial Alzheimers disease Neurodegeneration 5, 213-218
125. Tysoe, C., Whittaker, J., Xuereb, J., Cairns, N. J., Cruts, M., Van Broeckhoven, C., Wilcock, G., and Rubinsztein, D. C. (1998) A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease Am. J. Hum. Genet. 62, 70-76
126. De Jonghe, C., Cruts, M., Rogaeva, E. A., Tysoe, C., Singleton, A., Vanderstichele, H., Meschino, W., Dermaut, B., Vanderhoeven, I., Backhovens, H., Vanmechelen, E., Morris, C. M., Hardy, J., Rubinsztein, D. C., St George-Hyslop, P. H., and Van Broeckhoven, C. (1999) Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimers disease by increased Aβ42 secretion Hum. Mol. Genet. 8, 1529-1540
127. Perez-Tur, J., Froelich, S., Prihar, G., Crook, R., Baker, M., Duff, K., Wragg, M., Busfield, F., Lendon, C., and Clark, R. F. 1995, A mutation in Alzheimers disease destroying a splice acceptor site in the presenilin-1 gene NeuroReport 7, 297-301
128. Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., Hardy, J., Levey, A. I., Gandy, S. E., Jenkins, N. A., Copeland, N. G., Price, D. L., and Sisodia, S. S. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo Neuron 17, 181-190
129. Podlisny, M. B., Citron, M., Amarante, P., Sherrington, R., Xia, W., Zhang, J., Diehl, T., Levesque, G., Fraser, P., Haass, C., Koo, E. H., Seubert, P., St George-Hyslop, P., Teplow, D. B., and Selkoe, D. J. (1997) Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue Neurobiol. Dis. 3, 325-337
130. Steiner, H., Romig, H., Grim, M. G., Philipp, U., Pesold, B., Citron, M., Baumeister, R., and Haass, C. (1999) The biological and pathological function of the presenilin-1 Δexon 9 mutation is independent of its defect to undergo proteolytic processing J. Biol. Chem. 274, 7615-7618
131. Sato, N., Hori, O., Yamaguchi, A., Lambert, J. C., Chartier-Harlin, M. C., Robinson, P. A., Delacourte, A., Schmidt, A. M., Furuyama, T., Imaizumi, K., Tohyama, M., and Takagi, T. (1999) A novel presenilin-2 splice variant in human Alzheimers disease brain tissue J. Neurochem. 72, 2498-2505
132. Sato, N., Imaizumi, K., Manabe, T., Taniguchi, M., Hitomi, J., Katayama, T., Yoneda, T., Morihara, T., Yasuda, Y., Takagi, T., Kudo, T., Tsuda, T., Itoyama, Y., Makifuchi, T., Fraser, P. E., St George-Hyslop, P., and Tohyama, M. (2001) Increased production of β-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2 J. Biol. Chem. 276, 2108-2114
133. Manabe, T., Katayama, T., Sato, N., Gomi, F., Hitomi, J., Yanagita, T., Kudo, T., Honda, A., Mori, Y., Matsuzaki, S., Imaizumi, K., Mayeda, A., and Tohyama, M. (2003) Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimers disease Cell Death Differ. 10, 698-708
134. Manabe, T., Ohe, K., Katayama, T., Matsuzaki, S., Yanagita, T., Okuda, H., Bando, Y., Imaizumi, K., Reeves, R., Tohyama, M., and Mayeda, A. (2007) HMGA1a: Sequence-specific RNA-binding factor causing sporadic Alzheimers disease-linked exon skipping of presenilin-2 pre-mRNA Genes Cells 12, 1179-1191
135. Ohe, K. and Mayeda, A. (2010) HMGA1a trapping of U1 snRNP at an authentic 5′ splice site induces aberrant exon skipping in sporadic Alzheimers disease Mol. Cell. Biol. 30, 2220-2228
136. Suzuki, Y., Ohta, K., Itoh, M., Sakoh-Sumitomo, Y., Mitsuda, T., Ueda, M., Hayakawa-Yano, Y., Li, S., Hida, Y., Inuzuka, T., Jung, Y. K., and Nakagawa, T. (2009) An alternative spliced mouse presenilin-2 mRNA encodes a novel secretase inhibitor FEBS Lett. 583, 1403-1408
137. Lee, S. F., Shah, S., Li, H., Yu, C., Han, W., and Yu, G. (2002) Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-β precursor protein and Notch J. Biol. Chem. 277, 45013-45019
138. Hu, Y. and Fortini, M. E. (2003) Different cofactor activities in secretase assembly: Evidence for a nicastrin-Aph-1 subcomplex J. Cell Biol. 161, 685-690
139. LaVoie, M. J., Fraering, P. C., Ostaszewski, B. L., Ye, W., Kimberly, W. T., Wolfe, M. S., and Selkoe, D. J. (2003) Assembly of the secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin J. Biol. Chem. 278, 37213-37222
140. Morais, V. A., Crystal, A. S., Pijak, D. S., Carlin, D., Costa, J., Lee, V. M., and Doms, R. W. (2003) The transmembrane domain region of nicastrin mediates direct interactions with APH-1 and the secretase complex J. Biol. Chem. 278, 43284-43291
141. Shirotani, K., Edbauer, D., Kostka, M., Steiner, H., and Haass, C. (2004) Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin: Identification of nicastrin mutants that selectively interact with APH-1 J. Neurochem. 89, 1520-1527
142. Fraering, P. C., LaVoie, M. J., Ye, W., Ostaszewski, B. L., Kimberly, W. T., Selkoe, D. J., and Wolfe, M. S. (2004) Detergent-dependent dissociation of active secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex Biochemistry 43, 323-333
143. Shirotani, K., Edbauer, D., Prokop, S., Haass, C., and Steiner, H. (2004) Identification of distinct secretase complexes with different APH-1 variants J. Biol. Chem. 279, 41340-41345
144. Saito, S., Takahashi-Sasaki, N., and Araki, W. (2005) Identification and characterization of a novel human APH-1b splice variant lacking exon 4 Biochem. Biophys. Res. Commun. 330, 1068-1072
145. Lee, S. F., Shah, S., Yu, C., Wigley, W. C., Li, H., Lim, M., Pedersen, K., Han, W., Thomas, P., Lundkvist, J., Hao, Y. H., and Yu, G. (2004) A conserved GXXXG motif in APH-1 is critical for assembly and activity of the secretase complex J. Biol. Chem. 279, 4144-4152
146. Zubenko, G. S., Hughes, H. B., Stiffler, J. S., Hurtt, M. R., and Kaplan, B. B. (1998) A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution Genomics 50, 121-128
147. Kehoe, P., Wavrant-De Vrieze, F., Crook, R., Wu, W. S., Holmans, P., Fenton, I., Spurlock, G., Norton, N., Williams, H., Williams, N., Lovestone, S., Perez-Tur, J., Hutton, M., Chartier-Harlin, M. C., Shears, S., Roehl, K., Booth, J., Van Voorst, W., Ramic, D., Williams, J., Goate, A., Hardy, J., and Owen, M. J. (1999) A full genome scan for late onset Alzheimers disease Hum. Mol. Genet. 8, 237-245
148. Confaloni, A., Crestini, A., Albani, D., Piscopo, P., Campeggi, L. M., Terreni, L., Tartaglia, M., and Forloni, G. (2005) Rat nicastrin gene: cDNA isolation, mRNA variants and expression pattern analysis Brain Res. Mol. Brain Res. 136, 12-22
149. Mitsuda, N., Yamagata, H. D., Zhong, W., Aoto, M., Akatsu, H., Uekawa, N., Kamino, K., Taguchi, K., Yamamoto, T., Maruyama, M., Kosaka, K., Takeda, M., Kondo, I., and Miki, T. (2006) A novel alternative splice variant of nicastrin and its implication in Alzheimer disease Life Sci. 78, 2444-2448
150. Capell, A., Kaether, C., Edbauer, D., Shirotani, K., Merkl, S., Steiner, H., and Haass, C. (2003) Nicastrin interacts with secretase complex components via the N-terminal part of its transmembrane domain J. Biol. Chem. 278, 52519-52523
151. Maillet, M., Robert, S. J., and Lezoualch, F. (2004) New insights into serotonin 5-HT4 receptors: A novel therapeutic target for Alzheimers disease? Curr. Alzheimer Res. 1, 79-85
152. Lezoualch, F. (2007) 5-HT4 receptor and Alzheimers disease: The amyloid connection Exp. Neurol. 205, 325-329
153. Cho, S. and Hu, Y. (2007) Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival Exp. Neurol. 203, 274-278
154. Robert, S. J. and Lezoualch, F. (2008) Distinct functional effects of human 5-HT4 receptor isoforms on β-amyloid secretion Neurodegener. Dis. 5, 163-165